-
Milkshake study reveals how gene variants affect cholesterol
fiercepharma
April 28, 2018
In a bid to better understand the effects of human genetics on cholesterol, a team of scientists had 800 people drink a fatty milkshake, take a drug for three weeks, then drink another milkshake.
-
Newly discovered ‘molecular guardian’ keeps cholesterol in check
fiercebiotech
November 17, 2017
While the cellular signals used to respond to low cholesterol are well known, the researchers said, it has been unclear how cells tackle high cholesterol.
-
Newly discovered ‘molecular guardian’ keeps cholesterol in check
fiercebiotech
November 17, 2017
Harvard University researchers haveidentifieda protein that helps keep cellular cholesterol levels under control. They c
-
Danish discovery can pave the way for more effective cholesterol medicine
worldpharmanews
September 22, 2017
More than 600,000 Danes are being treated with cholesterol lowering medicine. 98 per cent of them are treated with statins, which curb the body's own production of cholesterol so that the level of cholesterol falls.
-
Quest Diagnostics moves to more accurate, nonfasting cholesterol tests
biospectrumasia
September 12, 2017
Quest Diagnostics is the first national laboratory provider in the United States to enable accurate nonfasting lipid testing using the novel method in patient testing
-
Amgen’s uncontrolled LDL cholesterol lowering drug available in Singapore
biospectrumasia
July 04, 2017
Amgen's breakthrough treatment will help patients significantly reduce LDL cholesterol levels.
-
Sanofi and Regeneron posts positive Praluent cholesterol data
pharmafile
June 13, 2017
Sanofi and Regeneron posts positive Praluent cholesterol data
-
What You Need to Know About Cholesterol
drugs
March 28, 2017
It's important to understand the different types of cholesterol and how to influence their levels.
-
New Cholesterol Drugs May Beat Statins, But Price Tag Is High
drugs.com
March 20, 2017
Two different injectable drugs can lower cholesterol levels even further than statins do, potentially warding off future heart attacks or strokes, new research suggests.
-
Repatha demonstrates reduced need for apheresis in patients with high LDL-C in study
cphi-online
March 15, 2017
Data suggest an alternative option for patients.